시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
발효 키모신 시장 분석 및 예측(-2034년) : 유형, 제품, 용도, 기술, 구성 요소, 최종 사용자, 프로세스, 기능성, 재료 유형
Fermented Chymosin Market Analysis and Forecast to 2034: Type, Product, Application, Technology, Component, End User, Process, Functionality, Material Type
상품코드 : 1762124
리서치사 : Global Insight Services LLC
발행일 : 2025년 07월
페이지 정보 : 영문 387 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 6,582,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ￦ 7,968,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ￦ 9,354,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

발효 키모신 시장은 2024년의 48억 달러에서 2034년에는 71억 달러로 성장하고, CAGR은 약 4%를 나타낼 것으로 예측됩니다. 이 방법은 기존의 동물 유래 레넷에 대한 지속 가능하고 일관된 대안을 제공하여 생산 효율성과 제품 품질을 향상시킵니다.

업계 개요

세계의 관세와 지정학적 긴장은 특히 동아시아의 발효 키모신 시장에 큰 영향을 미치고 있습니다. 이러한 과제에 대처하고 있습니다. 중국은 수입에 대한 의존을 줄이기 위해 생명 공학의 진보에 투자하고 자급 자족에 대한 주력을 강화하고 있습니다. 웬네트워크의 전략적 다양화를 필요로 하는 지정학적 취약성에 직면하고 있습니다. 시장은 지정학적 안정성과 공급망의 탄력성을 조건으로 하여 대폭적인 확대가 전망되고 있습니다.

시장 세분화
유형 미생물, 비동물성, 재조합
제품 액체 키모신, 분말 키모신, 과립 키모신
용도 치즈 생산, 요구르트 제조, 우유 응고
기술 발효 기술, 생명 공학, 유전 공학
성분 효소 농축액, 안정제, 방부제
최종 사용자 유제품 산업, 식음료 산업, 생명 공학 기업
프로세스 배치 발효, 연속 발효, 공급 배치 발효
기능성 응고 효율, 순도 수준, 안정성
재료 유형 생물 재료, 합성 재료, 하이브리드 재료

시장 개요 :

발효 키모신 시장은 주로 치즈 제조에서 지속 가능하고 채식 친화적인 렌넷 대체품에 대한 수요가 증가함에 따라 현저한 성장을 이루고 있습니다. 그리고 유제품 부문이 시장의 주요 부문으로 부상하고 있습니다. 사물 유래와 미생물 유래의 키모신이 있으며, 이들은 채식주의자 증가나 동물 애호에 관한 소비자의 의식 증가에 의해 지지를 모으고 있습니다. 또한 발효 공정 최적화의 생명 공학 통합은 잠재적으로 생산 비용을 절감하고 기존 유제품 이외의 발효 키모신의 응용을 확대하는 혁신의 유망한 길을 제시합니다.

경쟁 개요

발효 키모신 시장은 치즈와 유제품 수요 증가에 견인되어 식음료 부문이 큰 점유율을 차지하는 다이나믹한 분포를 볼 수 있습니다. 식생활의 기호가 변화하고 있는 중간층 증가에 의해 급성장 시장으로서 대두되고 있습니다. 주요 시장의 규제 틀은 제품의 안전성과 품질 기준을 확보하고 시장의 역학을 형성하는 데 있어 매우 중요합니다. 하지만 엄격한 규제 준수나 다액의 R&D 투자의 필요성과 같은 과제는 여전히 남아 있습니다.

주요 동향과 촉진요인 :

발효 키모신 시장은 몇 가지 주요 동향과 촉진요인으로 현저한 성장을 이루고 있습니다. 바이오 테크놀로지의 진보는 또 하나의 중요한 추진력이며, 발효 키모신의 보다 효율적이고 비용 효율적인 생산을 가능하게 하고 있습니다. 치즈 생산자에게 일관된 확장 가능한 솔루션을 제공합니다. 또한, 규제 당국의 승인과 식품 안전 당국의 적극적인 잉크도 시장의 수락과 확대를 뒷받침하고 있습니다. 소비자의 선호도가 진화함에 따라 생산자는 제품 제공의 혁신과 개선을 위해 R&D에 투자하고 있습니다.

억제와 도전 :

발효 키모신 시장은 현재 몇 가지 중요한 억제요인과 어려움을 겪고 있습니다. 최종 사용자들 사이에서는 기존의 동물 유래 효소보다 발효 키모신이 우수하다는 인식이 제한되어 시장 침투를 방해하고 있습니다. 또한, 수익성에 영향을 미칠 수 있습니다. 또한, 미생물이나 식물 유래의 효소 등, 비용면에서 유리하고 특정의 소비자층에 어필할 수 있는 대체 응고제와의 경쟁도 격렬합니다. 복잡성은 기술적 과제를 가져오고 효율과 품질을 확보하기 위한 연구개발에 많은 투자를 필요로 합니다.

목차

제1장 발효 키모신 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 발효 키모신 시장 전망

제5장 발효 키모신 발효 키모신 시장 전략

제6장 발효 키모신 시장 규모

제7장 발효 키모신 시장 규모 : 유형별

제8장 발효 키모신 시장 : 제품별

제9장 발효 키모신 시장 : 용도별

제10장 발효 키모신 시장 : 기술별

제11장 발효 키모신 시장 : 성분별

제12장 발효 키모신 시장 : 최종 사용자별

제13장 발효 키모신 시장 : 프로세스별

제14장 발효 키모신 시장 : 기능성별

제15장 발효 키모신 시장 : 재료 유형별

제16장 발효 키모신 시장 : 지역별

제17장 경쟁 구도

제18장 기업 프로파일

KTH
영문 목차

영문목차

Fermented Chymosin Market is anticipated to expand from $4.8 billion in 2024 to $7.1 billion by 2034, growing at a CAGR of approximately 4%. Fermented Chymosin Market encompasses the production and distribution of chymosin enzyme derived through microbial fermentation, primarily for cheese manufacturing. This method offers a sustainable and consistent alternative to traditional animal-derived rennet, enhancing production efficiency and product quality. Rising consumer preference for vegetarian and halal-certified products, coupled with advancements in fermentation technology, is propelling market growth, with significant opportunities emerging in emerging economies and specialty cheese segments.

Industry Overview:

Global tariffs and geopolitical tensions are exerting considerable influence on the Fermented Chymosin Market, particularly in East Asia. Japan and South Korea are navigating these challenges by enhancing local production capabilities and forging strategic alliances to mitigate supply chain disruptions. China is intensifying its focus on self-sufficiency, investing in biotechnology advancements to reduce reliance on imports. Taiwan, while a key player in biotechnology, faces geopolitical vulnerabilities that necessitate strategic diversification of its supply chain networks. The parent market of industrial enzymes is experiencing robust growth, driven by increasing demand in the food and beverage sector. By 2035, the Fermented Chymosin Market is expected to witness significant expansion, contingent on geopolitical stability and supply chain resilience. Concurrently, Middle East conflicts continue to affect global energy prices, indirectly influencing production costs.

Market Segmentation
TypeMicrobial, Animal-Free, Recombinant
ProductLiquid Chymosin, Powdered Chymosin, Granulated Chymosin
ApplicationCheese Production, Yogurt Manufacturing, Milk Coagulation
TechnologyFermentation Technology, Biotechnology, Genetic Engineering
ComponentEnzyme Concentrates, Stabilizers, Preservatives
End UserDairy Industry, Food and Beverage Industry, Biotechnology Firms
ProcessBatch Fermentation, Continuous Fermentation, Fed-Batch Fermentation
FunctionalityCoagulation Efficiency, Purity Levels, Stability
Material TypeBiological Material, Synthetic Material, Hybrid Material

Market Overview:

The Fermented Chymosin Market is experiencing notable growth, primarily driven by the increasing demand for sustainable and vegetarian-friendly rennet alternatives in cheese production. The dairy segment emerges as the leading market segment, attributed to the burgeoning global cheese consumption and the industry's shift towards non-animal-derived ingredients. This segment's dominance is further bolstered by advancements in fermentation technology, enhancing the efficiency and cost-effectiveness of chymosin production. Emerging sub-segments include plant-based and microbial chymosin, which are gaining traction due to the rising vegan population and heightened consumer awareness regarding animal welfare. These sub-segments are poised to impact the market significantly as they align with the broader trend of plant-based diets and sustainable food processing. Additionally, the integration of biotechnology in optimizing fermentation processes presents a promising avenue for innovation, potentially reducing production costs and expanding the application of fermented chymosin beyond traditional dairy products.

Geographical Overview:

The fermented chymosin market is witnessing diverse growth patterns across various regions. North America leads the market due to the increasing demand for cheese and other dairy products. The region's advanced biotechnology sector supports the production of high-quality chymosin, enhancing market growth. Europe follows closely, driven by its strong tradition of cheese production and a focus on sustainable and natural ingredients. Regulatory support for biotechnology in food production further bolsters the market. In the Asia Pacific, the market is expanding rapidly, spurred by rising consumer awareness of enzyme-based products. The region's burgeoning dairy industry and increasing disposable income contribute significantly to market growth. Latin America presents emerging opportunities, with a growing dairy sector and increasing adoption of biotechnology in food processing. The Middle East & Africa are also showing potential, as the demand for dairy products increases alongside urbanization and changing dietary preferences. These regions are recognizing the benefits of fermented chymosin, such as its efficiency and consistency in cheese production. The global market is poised for continuous growth, driven by technological advancements and increasing consumer demand for high-quality dairy products. Stakeholders in the industry should consider regional dynamics to capitalize on lucrative opportunities.

Competition Overview:

The fermented chymosin market is witnessing a dynamic distribution with the food and beverage sector holding a significant share, driven by the rising demand for cheese and dairy products. This trend is particularly pronounced in regions with a rich tradition of dairy consumption, such as Europe and North America. Meanwhile, the Asia-Pacific region is emerging as a burgeoning market due to increasing urbanization and a growing middle class with evolving dietary preferences. Key players are focusing on product innovation and expanding their geographical presence to capture a larger market share. Regulatory frameworks across major markets, including the FDA in the United States and EFSA in Europe, are pivotal in shaping market dynamics, ensuring product safety and quality standards. The market is projected to experience robust growth, fueled by advancements in biotechnology and the increasing trend towards sustainable and non-animal derived ingredients. However, challenges such as stringent regulatory compliance and the need for substantial R&D investments persist. Nevertheless, the burgeoning demand for plant-based and vegan-friendly products presents lucrative opportunities for market expansion.

Recent Developments:

The Fermented Chymosin Market has witnessed notable developments in recent months, reflecting its dynamic nature and growing importance. DSM-Firmenich announced a strategic partnership with a leading dairy producer to enhance the efficiency and sustainability of cheese production using their innovative fermented chymosin solutions. In a significant merger, two prominent biotechnology firms specializing in enzyme production have consolidated their operations to expand their reach and optimize their product offerings in the fermented chymosin sector. Regulatory changes in the European Union have streamlined the approval process for fermented chymosin products, facilitating quicker market entry and encouraging innovation. A notable product launch by a US-based biotech company introduced a new line of highly concentrated fermented chymosin, promising improved yield and cost-effectiveness for cheese manufacturers. Finally, an investment consortium led by a major venture capital firm has injected substantial capital into a startup focused on developing next-generation fermented chymosin, underscoring the market's potential for growth and innovation.

Key Companies:

Chr Hansen, Du Pont Nutrition and Biosciences, DSM Food Specialties, Kerry Group, Meiji Holdings, Novozymes, Biocatalysts, Sacco System, Enzyme Development Corporation, Renco New Zealand, Fonterra Cooperative Group, Caglificio Clerici, Mayasan Biotech, Enzybel Group, Amicogen, AB Enzymes, Advanced Enzyme Technologies, Royal Bioproducts, Renco Food Ingredients, Biocon

Key Trends and Drivers:

The Fermented Chymosin Market is experiencing notable growth, driven by several key trends and drivers. Increasing consumer demand for plant-based and lactose-free products is a significant trend, pushing manufacturers to explore alternative rennet sources like fermented chymosin. This shift aligns with the broader movement towards sustainable and ethical food production, appealing to environmentally conscious consumers. Advancements in biotechnology are another critical driver, enabling more efficient and cost-effective production of fermented chymosin. This technology reduces reliance on traditional animal-derived rennet, offering a consistent and scalable solution for cheese producers. Moreover, regulatory approvals and positive endorsements from food safety authorities are enhancing market acceptance and expansion. The growing global cheese consumption, especially in emerging economies, is fueling demand for high-quality rennet alternatives. As consumer preferences evolve, producers are investing in research and development to innovate and improve product offerings. This dynamic market environment presents lucrative opportunities for companies pioneering in fermented chymosin production, particularly those leveraging cutting-edge biotechnological processes.

Restraints and Challenges:

The Fermented Chymosin Market is currently navigating several significant restraints and challenges. A primary challenge is the stringent regulatory landscape, which imposes rigorous standards and compliance requirements that can be costly and time-consuming for manufacturers. Additionally, there is a limited awareness among end-users about the benefits of fermented chymosin over traditional animal-derived enzymes, which hampers market penetration. The market also contends with fluctuating raw material prices, which can lead to unpredictable production costs and affect profitability. Furthermore, there is intense competition from alternative coagulants, including microbial and plant-based enzymes, which can offer cost advantages and appeal to specific consumer segments. Finally, the complexity of scaling up production processes for fermented chymosin presents technical challenges, requiring significant investment in research and development to ensure efficiency and quality. These factors collectively pose hurdles to the market's expansion and necessitate strategic approaches to overcome them.

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Fermented Chymosin Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Fermented Chymosin Market Outlook

5: Fermented Chymosin Fermented Chymosin Market Strategy

6: Fermented Chymosin Market Size

7: Fermented Chymosin Market, by Type

8: Fermented Chymosin Market, by Product

9: Fermented Chymosin Market, by Application

10: Fermented Chymosin Market, by Technology

11: Fermented Chymosin Market, by Component

12: Fermented Chymosin Market, by End User

13: Fermented Chymosin Market, by Process

14: Fermented Chymosin Market, by Functionality

15: Fermented Chymosin Market, by Material Type

16: Fermented Chymosin Market, by Region

17: Competitive Landscape

18: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기